How patient stratification and pharmacogenetics affect ADRs in complex patients
- In: D8 - How patient stratification and pharmacogenetics affect ADRs in complex patients on Thursday, 5 September 2013, 14:00-17:00
- At: Dublin (Ireland) (2013)
- Type: Presentation
- By: ALFIREVIC, Ana (University of Liverpool, Liverpool, United Kingdom)
Drug hypersensitivity reactions or Type-B adverse drug reactions (ADRs) are unpredictable from the known pharmacology of the drug. They represent only about 20% of all ADRs, but are often serious and cause high morbidity and mortality. They range in severity from a mild skin rash to the most severe reactions with blistering skin rashes such as.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.